Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1800-0.0300 (-2.48%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.2100
Open1.1800
Bid0.0000 x 1800
Ask0.0000 x 2200
Day's range1.1800 - 1.2400
52-week range1.0600 - 9.9600
Volume96,971
Avg. volume224,478
Market cap30.111M
Beta (5Y monthly)1.44
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering

    Underwriters Exercise Their Option in FullFORT WORTH, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the closing of its previously announced underwritten offering of 10,675,001 shares of its common stock and warrants to purchase up to 5,337,501 shares of common stock. T

  • GlobeNewswire

    TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants

    FORT WORTH, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has priced a $10.675 million underwritten offering of 9,282,609 shares of its common stock and warrants to purchase up to 4,641,305 shares of common stock. The warrants are being sold at the rate of one

  • GlobeNewswire

    TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants

    FORT WORTH, Texas, Nov. 17, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it is offering to sell shares of its common stock and warrants to purchase common stock in an underwritten public offering. All of the securities in the offering are being sold by the TFF Pharmaceuticals, I